1.0Lebanon News Gazettehttps://lebanonnewsgazette.comlnadminhttps://lebanonnewsgazette.com/author/lnadmin/rich600338<blockquote class="wp-embedded-content" data-secret="40X5Y1PLfo"><a href="https://lebanonnewsgazette.com/aum-biosciences-receives-u-s-fda-rare-pediatric-disease-designation-for-aum302-for-treatment-of-neuroblastoma/">AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://lebanonnewsgazette.com/aum-biosciences-receives-u-s-fda-rare-pediatric-disease-designation-for-aum302-for-treatment-of-neuroblastoma/embed/#?secret=40X5Y1PLfo" width="600" height="338" title="“AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma” — Lebanon News Gazette" data-secret="40X5Y1PLfo" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> AUM302 is potentially eligible to receive a rare pediatric disease priority review voucher at the time of marketing approval SINGAPORE and BETHESDA, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug […]https://ci6.googleusercontent.com/proxy/ZXYTmiyhO80FFkMWIOziO9DGrKHcLyfJsGYJV5mS0Yv5FCOUjc-UnVuUxii7dhEUtra8tFXl5pDX_BaBGIF0MJRjrjju6r6bqlOUY0DWqkrK_wNNiGm2PcPu9T_xPxIQVjl7caC622XmxwYBi9aCroiH2KuULeYFHmrHa4NlmEEuaQVKDrgMPLZfA8zQybaUxNhpkw=s0-d-e1-ft#https://ml.globenewswire.com/media/ZjU1NjM2NjMtY2FjNC00ZDFlLTk4MzgtMDRlOTQ5MmNmOGU3LTEyNTg3Mzc=/tiny/AUM-Biosciences-Pte-Ltd.png